Back to search
FDAFDA · Food and drugs·Recall number Z-0965-2026

LifeShield Drug Library Management (DLM); LifeShield Infusion Safety Software Suite v2.2 List Number 17003-02

Published December 31, 2025 · Recall initiated: November 24, 2025

Summary

FDA records medical device Class II recall Z-0965-2026, published December 31, 2025 and initiated November 24, 2025. Recalling firm: ICU Medical, Inc.; Status: Ongoing; Reported quantity: 7 customers; Lot: version 2.2.1 UDI-DI 00887709127227 Issue affects customers who migrated from LifeShield DLM v2.1x to LifeShield DLM v2.2.1 and have any version of a Plum Duo v1.1 drug library that was approved or locked for review before the migration. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

For certain customers, the Change Summary review option ceases to operate as expected for any migrated library after the migration has been completed. Users must use alternate methods to review changes. Failure to do so may lead in over delivery, under delivery, or delay in setup on the infusion pump.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ICU Medical, Inc.
Distributor
US Nationwide distribution in the states of CA, IA, LA, NY, PA, TN, VA.
Lot
version 2.2.1 UDI-DI 00887709127227 Issue affects customers who migrated from LifeShield DLM v2.1x to LifeShield DLM v2.2.1 and have any version of a Plum Duo v1.1 drug library that was approved or locked for review before the migration.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LifeShield Drug Library Management (DLM); LifeShield Infusion Safety Software Suite v2.2 List Number 17003-02 recalled?

Yes. FDA published recall Z-0965-2026 on December 31, 2025. Reported hazard: For certain customers, the Change Summary review option ceases to operate as expected for any migrated library after the migration has been completed. Users must use alternate methods to review changes. Failure to do so may lead in over delivery, under delivery, or delay in setup on the infusion pump.

What should I do if I have this product?

Voluntary: Firm initiated · Letter